Literature DB >> 11684887

How should insulin-like growth factor I be measured? A consensus statement.

M B Ranke1, U Feldt-Rasmussen, P Bang, R C Baxter, C Camacho-Hübner, D R Clemmons, A Juul, H Orskov, C J Strasburger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11684887     DOI： 10.1159/000063485

Source DB:  PubMed          Journal:  Horm Res        ISSN： 0301-0163


× No keyword cloud information.
  3 in total

1.  Variability and reliability of single serum IGF-I measurements: impact on determining predictability of risk ratios in disease development.

Authors:  Daniela Milani; John D Carmichael; Joan Welkowitz; Steven Ferris; Richard E Reitz; Ann Danoff; David L Kleinberg
Journal:  J Clin Endocrinol Metab       Date:  2004-05       Impact factor: 5.958

Review 2.  Pre-analytic considerations for the proper assessment of hormones of the hypothalamic-pituitary axis in epidemiological research.

Authors:  Rachel L Derr; Scott J Cameron; Sherita Hill Golden
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

3.  Reference ranges for an automated chemiluminescent assay for serum insulin-like growth factor I (IGF-I) in a large population of healthy adults from Buenos Aires.

Authors:  M Guitelman; F Smithuis; N Garcia Basavilbaso; C Aranda; B Fabre; A Oneto
Journal:  J Endocrinol Invest       Date:  2015-03-05       Impact factor: 4.256
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.